Hillchol: Bharat Biotech’s oral cholera vaccine demonstrates success in phase III clinical studies EP News Bureau May 21, 2025 Hillchol has demonstrated against both Ogawa and Inaba serotypes, and aims to address the global shortage of cholera vaccines
Hilleman licenses oral cholera vaccine Hillchol to Bharat Biotech EP News Bureau Jun 26, 2019 Collaboration seeks to accelerate the development, licensure, manufacture and supply of an affordable, next-generation cholera…
